Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Molecular mechanism of the RNA helicase DHX37 and its activation by UTP14A in ribosome biogenesis.

Autor: Boneberg FM; Department of Biochemistry, University of Zurich, CH-8057 Zurich, Switzerland., Brandmann T; Department of Biochemistry, University of Zurich, CH-8057 Zurich, Switzerland., Kobel L; Department of Biochemistry, University of Zurich, CH-8057 Zurich, Switzerland., van den Heuvel J; Department of Biology, Institute of Biochemistry, ETH Zurich, CH-8093 Zurich, Switzerland., Bargsten K; Department of Biochemistry, University of Zurich, CH-8057 Zurich, Switzerland., Bammert L; Department of Biology, Institute of Biochemistry, ETH Zurich, CH-8093 Zurich, Switzerland., Kutay U; Department of Biology, Institute of Biochemistry, ETH Zurich, CH-8093 Zurich, Switzerland., Jinek M; Department of Biochemistry, University of Zurich, CH-8057 Zurich, Switzerland.

Publikováno v: RNA (New York, N.Y.) [RNA] 2019 Jun; Vol. 25 (6), pp. 685-701. Date of Electronic Publication: 2019 Mar 25.

Fragile X Messenger Ribonucleoprotein Protein and Its Multifunctionality: From Cytosol to Nucleolus and Back.

Autor: Taha, Mohamed S.^1,2 (AUTHOR) mohamed.taha@hhu.de, Ahmadian, Mohammad Reza¹ (AUTHOR) reza.ahmadian@hhu.de

Publikováno v: Biomolecules (2218-273X). Apr2024, Vol. 14 Issue 4, p399. 14p.

Amino acid-dependent signaling via S6K1 and MYC is essential for regulation of rDNA transcription.

Autor: Kang J; Oncogenic Signaling and Growth Control Program, Peter MacCallum Cancer Centre, St Andrews Place, East Melbourne, Victoria, Australia., Kusnadi EP; Oncogenic Signaling and Growth Control Program, Peter MacCallum Cancer Centre, St Andrews Place, East Melbourne, Victoria, Australia., Ogden AJ; Oncogenic Signaling and Growth Control Program, Peter MacCallum Cancer Centre, St Andrews Place, East Melbourne, Victoria, Australia., Hicks RJ; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.; Molecular Imaging and Targeted Therapeutics Laboratory, Cancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia., Bammert L; Institute of Biochemistry, Department of Biology, Swiss Federal Institute of Technology Zurich, Zurich, Switzerland., Kutay U; Institute of Biochemistry, Department of Biology, Swiss Federal Institute of Technology Zurich, Zurich, Switzerland., Hung S; Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital & Department of Ophthalmology, University of Melbourne, East Melbourne, Victoria, Australia., Sanij E; Oncogenic Signaling and Growth Control Program, Peter MacCallum Cancer Centre, St Andrews Place, East Melbourne, Victoria, Australia., Hannan RD; Oncogenic Signaling and Growth Control Program, Peter MacCallum Cancer Centre, St Andrews Place, East Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.; Department of Biochemistry and Molecular Biology, University of Melbourne, Parkville, Victoria, Australia.; Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria, Australia.; School of Biomedical Sciences, University of Queensland, Brisbane, Queensland, Australia.; Department of Cancer Biology and Therapeutics, The John Curtin School of Medical Research, The Australian National University, Canberaa, ACT, Australia., Hannan KM; Department of Biochemistry and Molecular Biology, University of Melbourne, Parkville, Victoria, Australia.; Department of Cancer Biology and Therapeutics, The John Curtin School of Medical Research, The Australian National University, Canberaa, ACT, Australia., Pearson RB; Oncogenic Signaling and Growth Control Program, Peter MacCallum Cancer Centre, St Andrews Place, East Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.; Department of Biochemistry and Molecular Biology, University of Melbourne, Parkville, Victoria, Australia.; Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria, Australia.

Publikováno v: Oncotarget [Oncotarget] 2016 Aug 02; Vol. 7 (31), pp. 48887-48904.

The NF45/NF90 Heterodimer Contributes to the Biogenesis of 60S Ribosomal Subunits and Influences Nucleolar Morphology.

Autor: Wandrey F; Institute of Biochemistry, ETH Zurich, Zurich, Switzerland., Montellese C; Institute of Biochemistry, ETH Zurich, Zurich, Switzerland Molecular Life Sciences Ph.D. Program, Zurich, Switzerland., Koos K; Synthetic and Systems Biology Unit, Hungarian Academy of Sciences, BRC, Szeged, Hungary., Badertscher L; Institute of Biochemistry, ETH Zurich, Zurich, Switzerland Molecular Life Sciences Ph.D. Program, Zurich, Switzerland., Bammert L; Institute of Biochemistry, ETH Zurich, Zurich, Switzerland Molecular Life Sciences Ph.D. Program, Zurich, Switzerland., Cook AG; Wellcome Trust Centre for Cell Biology, University of Edinburgh, Edinburgh, United Kingdom., Zemp I; Institute of Biochemistry, ETH Zurich, Zurich, Switzerland., Horvath P; Synthetic and Systems Biology Unit, Hungarian Academy of Sciences, BRC, Szeged, Hungary., Kutay U; Institute of Biochemistry, ETH Zurich, Zurich, Switzerland ulrike.kutay@bc.biol.ethz.ch.

Publikováno v: Molecular and cellular biology [Mol Cell Biol] 2015 Oct; Vol. 35 (20), pp. 3491-503. Date of Electronic Publication: 2015 Aug 03.